In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NDI Medical LLC

www.ndimedical.com

Latest From NDI Medical LLC

Neuromodulation Devices Stimulate Opportunities In Urology

Neuromodulation for urological indications, notably overactive bladder (OAB), has been dominated since the late 1990s by Medtronic’s sacral-nerve stimulation system InterStim, with the more recent addition of Cogentix Medical’s Urgent PC for tibial nerve stimulation. Yet only a fraction of OAB patients receive effective neuromodulation treatment, and several companies hope to lower barriers to this modality by developing alternative devices for urological indications.

Medical Device Innovation

Deep Brain Innovations Debuts At Neurotech Conference

A new company created by NDI Medical has a novel deep-brain stimulation algorithm for treating Parkinson’s disease, which, according to the firm, requires less power and may be more effective than currently available DBS systems for Parkinson’s.

Medical Device

Emerging Peripheral Nerve Technologies Draw New Competitors To Neuromodulation Market

Emerging technologies in peripheral nerve stimulation are expected to play a pivotal role in opening up new markets and driving growth in the neuromodulation device market in the years ahead. As a result, the pipeline is rich with products designed to address a growing number of patients with long-term pain and other chronic conditions, many of whom have no other treatment options.

Medical Device

NDI Medical's Spin-Off Model for Neurostimulation

The neurostimulation market is becoming electric for many large companies looking for major growth opportunities. Worth $1.3 billion in the US in 2009, the neurostimulation market is expected to grow to $2.7 billion by the year 2014. Those robust figures take into account some fourteen different clinical product categories, some of the largest being Alzheimer's disease, chronic pain, depression, epilepsy, obstructive sleep apnea, obesity, and stroke. In fact, that's the beauty of neurostimulation for medical device companies: it offers a single platform technology that can be leveraged over multiple, large product areas. But what model most efficiently helps a company with core expertise in neurostimulation - the knowledge of impulse generators and leads and their interface with nerves, power sources, and controllers - leverage that knowledge over numerous product areas? NDI Medical has its own strategy with a for-profit incubator solely focused on neurostimulation.
Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • NDI Medical Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NDI Medical LLC
  • Senior Management
  • Geoffrey Thrope, Pres. & CEO
    Robert Blankenship, EVP, Fin. & CFO
  • Contact Info
  • NDI Medical LLC
    Phone: (216) 378-9106
    22901 Millcreek Blvd.
    Ste. 110
    Cleveland , OH 44122
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register